Marta Llaurado-Fernandez
Papers
1
Total Citations
13
H-Index
1
About
Dr. Marta Llaurado-Fernandez is a translational cancer researcher whose work centers on low-grade serous ovarian carcinoma (LGSOC), a rare and molecularly distinct ovarian malignancy often underrepresented in clinical trials. Her major contribution lies in pioneering high-throughput drug screening to identify novel, targeted therapeutics for LGSOC, directly addressing a critical gap in treatment options for this underserved patient population. Her 2024 study on this topic has already garnered 13 citations, underscoring its timely impact. By focusing on the unique biology of LGSOC—separate from the more common high-grade serous carcinoma—Dr. Llaurado-Fernandez is helping to redefine therapeutic strategies for rare ovarian cancers. Her work not only advances precision oncology but also provides a blueprint for drug discovery in other rare tumor types. For students and researchers, her research exemplifies how targeted, mechanism-driven approaches can transform outcomes in diseases long neglected by standard clinical trial frameworks.
Research Focus
Key Achievements
Top Papers
- 1